Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ingram

Showing results (381-390 of 507) with videos related to

Pageof 51
Sort By:
Health Technology Assessment (Winchester, England)|December 27, 2023
Treatment of Hidradenitis Suppurativa Evaluation Study: the THESEUS prospective cohort studyJohn R Ingram, Janine Bates, Rebecca Cannings-John, et al.
The British Journal of Dermatology|August 12, 2025
The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient reported outcomes for hidradenitis suppurativaJohn R Ingram, Magdalena B Wozniak, Anna Passera, et al.
The Journal of Experimental Medicine|July 2, 2017
Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cellsMohammad Rashidian, Jessica R Ingram, Michael Dougan, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2014
Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countriesBenjamin A Rogers, Paul R Ingram, Naomi Runnegar, et al.
Dermatology and Therapy|February 8, 2025
Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design OverviewJohn R Ingram, Georgios Kokolakis, Barry M McGrath, et al.
The British Journal of Dermatology|May 18, 2023
Research priorities in the management of hidradenitis suppurativaPaul Leighton, Laura Howells, Janine Bates, et al.
BMJ Open|February 6, 2024
Protocol of a scoping review of outcome domains in dermatologyUmer Nadir, Areeba Ahmed, Michael D Yi, et al.
Nature|October 22, 2013
Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virusStephanie K Dougan, Joseph Ashour, Roos A Karssemeijer, et al.
Archives of Pathology & Laboratory Medicine|October 14, 2020
Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous MelanomaWoo Cheal Cho, Wei-Lien Wang, Denái R Milton, et al.
American Journal of Clinical Dermatology|March 10, 2026
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt TreatmentAntonio Martorell, John R Ingram, Christopher J Sayed, et al.
Pageof 51

Showing results (381-390 of 507) with videos related to

Sort By:
Pageof 51
Health Technology Assessment (Winchester, England)|December 27, 2023
Treatment of Hidradenitis Suppurativa Evaluation Study: the THESEUS prospective cohort studyJohn R Ingram, Janine Bates, Rebecca Cannings-John, et al.
The British Journal of Dermatology|August 12, 2025
The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient reported outcomes for hidradenitis suppurativaJohn R Ingram, Magdalena B Wozniak, Anna Passera, et al.
The Journal of Experimental Medicine|July 2, 2017
Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cellsMohammad Rashidian, Jessica R Ingram, Michael Dougan, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2014
Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countriesBenjamin A Rogers, Paul R Ingram, Naomi Runnegar, et al.
Dermatology and Therapy|February 8, 2025
Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design OverviewJohn R Ingram, Georgios Kokolakis, Barry M McGrath, et al.
The British Journal of Dermatology|May 18, 2023
Research priorities in the management of hidradenitis suppurativaPaul Leighton, Laura Howells, Janine Bates, et al.
BMJ Open|February 6, 2024
Protocol of a scoping review of outcome domains in dermatologyUmer Nadir, Areeba Ahmed, Michael D Yi, et al.
Nature|October 22, 2013
Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virusStephanie K Dougan, Joseph Ashour, Roos A Karssemeijer, et al.
Archives of Pathology & Laboratory Medicine|October 14, 2020
Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous MelanomaWoo Cheal Cho, Wei-Lien Wang, Denái R Milton, et al.
American Journal of Clinical Dermatology|March 10, 2026
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt TreatmentAntonio Martorell, John R Ingram, Christopher J Sayed, et al.
Pageof 51